Nathan Kerr

Dr Nathan Kerr, is a fellowship-trained glaucoma subspecialist in Melbourne, Australia. A recipient of the Bayer Scholarship, he completed a prestigious fellowship at Moorfields Eye Hospital in London where he trained in Minimally Invasive Glaucoma Surgery (MIGS) under world-renowned surgeon Mr Keith Barton. Dr Kerr was amongst the first surgeons in Australia to be accredited in the use of several novel MIGS procedures.

Dr Kerr’s primary research interest is the surgical management of glaucoma, in particular to determine the safety, clinical efficacy, cost-effectiveness, and impact on quality of life of newer minimally invasive surgical techniques compared to traditional techniques. He serves as a Glaucoma Section Editor for Clinical and Experimental Ophthalmology and is the Glaucoma Surgical Trial Lead at the Centre for Eye Research Australia. Dr Kerr is the Principal Investigator for the first-in-human clinical trial of the PolyActiva ocular implant and OccuRx oral anti-fibrotic medication.